focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFair Oaks Inc21 Regulatory News (FAIR)

Share Price Information for Fair Oaks Inc21 (FAIR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.5825
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.015 (2.609%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 0.5825
FAIR Live PriceLast checked at -
Fair Oaks Income 2017 is an Investment Trust

To generate attractive, risk-adjusted returns, principally through income distributions, mainly invests in US and European CLOs or other vehicles.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of Extraordinary General Meeting

19 Apr 2021 18:29

RNS Number : 9543V
Fair Oaks Income Limited
19 April 2021
 

19 April 2021

 

Fair Oaks Income Limited

(Incorporated in Guernsey under The Companies (Guernsey) Law, 2008, as amended, with registered number 58123 and registered as a Registered Closed-ended Collective Investment Scheme with the Guernsey Financial Services Commission)

 

Result of Extraordinary General Meeting

 

Fair Oaks Income Limited (the "Company") announces that, at the Extraordinary General Meeting of the Company, resolutions 1 and 2 were passed but resolution 3 was not passed.

 

The Board acknowledges that Resolution 3 did not pass by a small margin and will consult with major shareholders ahead of proposing a resolution to disapply pre-emption rights at the forthcoming Annual General Meeting. Notwithstanding that Resolution 3 did not pass, the Reorganisation Proposal and admission of the re-designated 2021 Shares and Realisation Shares, as set out in the Company's announcement released earlier today, will proceed.

 

The votes received by the Company were as follows:

 

Resolution

For

Against

Withheld*

Votes

%

Votes

%

Votes

1. Revised Articles of Incorporation.

266,089,814

83.08

54,207,406

16.92

14,790

2. Redesignation of 2017 Shares.

266,089,814

83.08

54,207,406

16.92

14,790

3. Authority to issue shares and placing programme.

237,885,675

74.27

82,411,545

25.73

14,790

 

*A vote withheld is not a vote in law and is therefore not counted towards the proportion of votes "For" or "Against" the resolution.

 

The full text of each resolution is detailed below:

 

1. THAT, conditional upon the passing of Resolution 2, the articles of incorporation in the form produced to the meeting and initialled by the Chairman of the meeting for the purposes of identification be and are hereby approved and adopted as the articles of incorporation of the Company in substitution for, and to the exclusion of, the existing articles of incorporation of the Company.

 

2. THAT on the Effective Date (as defined in the circular issued by the Company to the Shareholders dated 26 March 2021 (the "Circular")) all ordinary shares of no par value each in the capital of the Company designated as "2017 shares" ("2017 Shares") shall be re-designated on a one-for-one basis as ordinary shares of no par value each in the capital of the Company designated as "2021 shares" ("2021 Shares") pursuant to the proposals set out in the Circular, EXCEPT THAT where and to the extent that a shareholder has made a valid election for the re-designation of some or all of their 2017 Shares as ordinary shares of no par value each in the capital of the Company designated as "Realisation Shares" ("Realisation Shares") pursuant to an election contemplated under the Circular (and provided that the aggregate net asset value (as at 31 March 2021) of the 2017 Shares elected for Realisation Shares exceeds US$30 million), such 2017 Shares shall instead be re-designated on a one-for-one basis as Realisation Shares.

 

3. THAT the Directors of the Company be and are hereby empowered to issue the following shares in the Company or rights to subscribe for such shares in the Company for cash as if the pre-emption provisions contained under Article 6.2 did not apply to any such issues provided that this power shall be limited to the issue of the below-mentioned shares or of rights to subscribe for the below-mentioned shares:

 

(i) up to a maximum number of 350 million C Shares under the Placing Programme ("Placing Programme" as defined in the Circular); and

(ii) up to such number of 2021 Shares under the Placing Programme as represents 20 per cent. of the 2021 Shares then in issue following the Effective Date, and

 

subject to any issues of 2021 Shares and/or C Shares under the Placing Programme being capped at an aggregate issue value of US$350 million, and that such power shall expire on the earlier of the 2022 AGM Date (as defined in the Circular) or on the expiry of 15 months from the passing of this Resolution except that the Company may before such expiry make offers or agreements which would or might require C Shares and/or 2021 Shares or rights to subscribe for such shares in the Company to be issued after such expiry and notwithstanding such expiry the Directors may issue C Shares and/or 2021 Shares or rights to subscribe for such shares in the Company in pursuance of such offers or agreements as if the power conferred hereby had not expired.

 

LEI: 2138008KETEC1WM5YP90

 

Enquiries:

 

Fair Oaks Income Limited

Email: contact@fairoaksincome.com

Web: www.fairoaksincome.com

 

Fair Oaks Capital Limited

Investor Relations

DDI: +44 (0) 20 3034 0400

Email: ir@fairoakscap.com

 

Praxis Fund Services Limited

Ben Le Prevost

DDI: +44 (0) 1481 755524

Email: Ben.LePrevost@praxisifm.com

 

Numis Securities Limited

Nathan Brown, Corporate Broking

DDI: +44 (0) 20 7260 1426

Email: n.brown@numis.com

 

Liberum Capital Limited

Chris Clarke, Investment Banking

DDI: +44 (0) 20 3100 2190

Email: chris.clarke@liberum.com

 

Fair Oaks Income Limited

 

Fair Oaks Income Limited is a registered closed-ended investment company incorporated in Guernsey. The Company was admitted to trading on the Specialist Fund Market of the London Stock Exchange (now the Specialist Fund Segment of the Main Market of the London Stock Exchange) on 12 June 2014.

 

The investment policy of the Company is to invest (either directly and/or indirectly through FOMC II LP) in US and European CLOs or other vehicles and structures which provide exposure to portfolios consisting primarily of US and European floating-rate senior secured loans and which may include non-recourse financing.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ROMEAXLNFADFEFA
Date   Source Headline
14th Apr 20227:00 amRNSAnnual Financial Report
14th Apr 20227:00 amRNSNet Asset Value(s)
17th Mar 20227:00 amRNSNet Asset Value(s)
24th Feb 20223:37 pmRNSDividend Currency Election
17th Feb 20227:00 amRNSNet Asset Value(s)
7th Feb 20225:17 pmRNSDividend Declaration
31st Jan 20225:15 pmRNSReinvestment of Management Fees
20th Jan 20227:00 amRNSNet Asset Value(s)
14th Dec 20217:00 amRNSNet Asset Value(s)
9th Dec 20217:00 amRNSPortfolio Update
7th Dec 20215:00 pmRNSAcquisition of Praxis Fund Services by Sanne Group
15th Nov 20217:00 amRNSNet Asset Value(s)
12th Nov 202110:36 amRNSDividend Currency Election
26th Oct 20211:05 pmRNSDividend Declaration
22nd Oct 20219:48 amRNSPortfolio Update
19th Oct 20213:12 pmRNSReinvestment of Management Fees
14th Oct 20217:00 amRNSPortfolio Update
14th Oct 20217:00 amRNSNet Asset Value(s)
16th Sep 20218:01 amRNSNet Asset Value(s)
9th Sep 20217:00 amRNSHalf-year Report
16th Aug 20217:00 amRNSNet Asset Value(s)
10th Aug 20212:23 pmRNSDividend Declaration
4th Aug 20219:13 amRNSReinvestment of Management Fees
21st Jul 20217:00 amRNSNet Asset Value(s)
5th Jul 20217:00 amRNSPortfolio Update
16th Jun 20217:00 amRNSNet Asset Value(s)
3rd Jun 20213:35 pmRNSDividend Currency Election
27th May 20217:00 amRNSPortfolio Update
21st May 202110:51 amRNSResult of AGM
20th May 20217:00 amRNSDividend Declaration
20th May 20217:00 amRNSNet Asset Value(s)
30th Apr 20215:24 pmRNSTotal Voting Rights
30th Apr 20215:13 pmRNSNotice of AGM
28th Apr 20219:10 amRNSPublication of Suppl.Prospcts
26th Apr 20217:00 amRNSAnnual Financial Report
22nd Apr 202112:08 pmRNSReinvestment of Management Fees
19th Apr 20216:29 pmRNSResult of Elections
19th Apr 20216:29 pmRNSResult of Extraordinary General Meeting
9th Apr 20217:00 amRNSNet Asset Value(s)
29th Mar 20217:00 amRNSReorganisation Proposal and Placing Programme
23rd Mar 20213:28 pmRNSHolding(s) in Company
18th Mar 20217:00 amRNSPortfolio Update
11th Mar 20217:00 amRNSNet Asset Value(s)
18th Feb 20213:02 pmRNSDividend Currency Election
18th Feb 20217:00 amRNSNet Asset Value(s)
2nd Feb 20217:00 amRNSDividend Declaration
2nd Feb 20217:00 amRNSNet Asset Value(s)
15th Jan 20213:18 pmRNSHolding(s) in Company
14th Dec 20207:00 amRNSNet Asset Value(s)
30th Nov 20201:57 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.